Doubling clopidogrel dose in ACS
Links shared publicly online about this topic.
- 1,785total visits
Doubling clopidogrel dose in ACS
View full resource at theheart.org
Tags: Bleeding, Disease and Condition, Anti-Clotting Medication, Plavix, Iscover
Most Recently Shared on August 30, 2009 at 3:55 pm By:
heartwire: CURRENT OASIS-7: Benefit to doubling clopidogrel dose in ACS patients undergoing PCI http://bit.ly/12xYSx
Cilostazol Matches Double-Dose Clopidogrel Following PCI : Cardiology News
ecardiologynews.com — “Cardiology News is an independent news source that provides cardiologists with timely and relevant news and commentary about clinical developments and the impact of health care policy on cardiology and the cardiologist's practice. Cardiology News Digital Network is the online destination and multimedia properties of Cardiology News, the independent news publication for cardiologists. Cardiology news is the leading source of news and commentary about clinical developments in cardiology as well as” View full resource at ecardiologynews.com
Most Recently Shared on March 26, 2012 at 5:37 pm By:
Cardiology News Cardiology and Health News
Cilostazol Matches Double-Dose Clopidogrel Following PCI http://t.co/ZqlJxFju
Prasugrel Bests Double-Dose Clopidogrel in Clopidogrel Nonresponders : Cardiology News
ecardiologynews.com — “Cardiology News is an independent news source that provides cardiologists with timely and relevant news and commentary about clinical developments and the impact of health care policy on cardiology and the cardiologist's practice. Cardiology News Digital Network is the online destination and multimedia properties of Cardiology News, the independent news publication for cardiologists. Cardiology news is the leading source of news and commentary about clinical developments in cardiology as well as” View full resource at ecardiologynews.com
Most Recently Shared on March 25, 2012 at 4:34 pm By:
Bob Finn - Medical News Net Health News
Patients on clopidogrel for stable coronary disease benefit more from switching to prasugrel than doubling the dose - http://t.co/96ca10hr
Prasugrel Bests Double-Dose Clopidogrel in Clopidogrel Nonresponders : Cardiology News
ecardiologynews.com — “Cardiology News is an independent news source that provides cardiologists with timely and relevant news and commentary about clinical developments and the impact of health care policy on cardiology and the cardiologist's practice. Cardiology News Digital Network is the online destination and multimedia properties of Cardiology News, the independent news publication for cardiologists. Cardiology news is the leading source of news and commentary about clinical developments in cardiology as well as” View full resource at ecardiologynews.com
Most Recently Shared on March 25, 2012 at 3:47 pm By:
Cardiology News Cardiology and Health News
Prasugrel Bests Double-Dose Clopidogrel in Clopidogrel Nonresponders http://t.co/h24S9qeO
JAMA: Platelet testing shows promise, but still no reason for widespread adoption
cardiovascularbusiness.com — “Among patients with acute coronary syndromes (ACS) undergoing a procedure such as angioplasty, those who received platelet function tests before receiving anti-thrombotic therapy to determine appropriate clopidogrel dosing and who had high residual platelet reactivity were at an increased risk of an ischemic event at short- and long-term follow-up of up to two years, according to the results of the RECLOSE 2-ACS study in the Sept. 21 issue of the Journal of the American Medical Association. Howe” View full resource at cardiovascularbusiness.com
Most Recently Shared on September 21, 2011 at 4:29 pm By:
CardioBusiness Health Magazine
JAMA: Platelet testing shows promise, but still no reason for widespread adoption http://t.co/b1QxyRLi
HRPR before PCI procedures linked to increased risk of ischemic event in ACS patients
news-medical.net — “Among patients with acute coronary syndromes undergoing a procedure such as angioplasty, those who received platelet function tests before receiving antithrombotic therapy to determine appropriate clopidogrel dosing and who had high residual platelet reactivity were at an increased risk of an ischemic event at short- and long-term follow-up of up to 2 years, according to a study in the September 21 issue of JAMA.” View full resource at news-medical.net
Most Recently Shared on September 21, 2011 at 12:09 pm By:
Stroke News: HRPR before PCI procedures linked to increased risk of ischemic event in ACS patients: Among pati... http://t.co/nmPz3eUp
ScienceDirect - Thrombosis Research : Doubling the dose of Clopidogrel restores the loss of antiplatelet effect induced by esomeprazole
sciencedirect.com — “ScienceDirect - Thrombosis Research : Doubling the dose of Clopidogrel restores the loss of antiplatelet effect induced by esomeprazole” View full resource at sciencedirect.com
Most Recently Shared on July 27, 2011 at 10:37 pm By:
Edgar Avalos, MD Neurology and Health Group
Doubling the dose of Clopidogrel restores the loss of antiplatelet effect induced by esomeprazole http://t.co/nOuxLmH
Poor Clopidogrel Responders With ACS Face High Risk of Death - QualityPoint Technologies
qualitypointtech.net — “After a number of negative trials in stable coronary disease, the RECLOSE 2 ACS study, using light-transmittance aggregometry to assess platelet reactivity, shows that ACS nonresponders to clopidogrel face much higher rates of adverse ischemic events and cardiac death after PCI than responders and that doubling the clopidogrel dose doesn't improve their odds. Heartwire” View full resource at qualitypointtech.net
Most Recently Shared on May 19, 2011 at 11:00 pm By:
Poor Clopidogrel Responders With ACS Face High Risk of Death: After a number of negative trials in stable coronary... http://bit.ly/lJHUkG
Medical News: Double Dose Plavix No Benefit After Stenting - in Cardiovascular, PCI from MedPage Today
medpagetoday.com — “A double dose of clopidogrel (Plavix) following percutaneous coronary intervention does not appear to reduce cardiovascular events among stent patients with high platelet reactivity on a standard dose” View full resource at medpagetoday.com
Most Recently Shared on March 16, 2011 at 9:36 pm By:
Tammi Jacobs Health Professional
Double Dose Plavix No Benefit After Stenting http://bit.ly/hg8TZq
Medical News: Double Dose Plavix No Benefit After Stenting - in Cardiovascular, PCI from MedPage Today
medpagetoday.com — “A double dose of clopidogrel (Plavix) following percutaneous coronary intervention does not appear to reduce cardiovascular events among stent patients with high platelet reactivity on a standard dose” View full resource at medpagetoday.com
Most Recently Shared on March 16, 2011 at 2:37 pm By:
Double Dose Plavix No Benefit After Stenting (CME/CE) http://bit.ly/eJjTxL
GRAVITAS Trial finds high dose of clopidogrel does not reduce risk of ischemic events
news-medical.net — “Accumetrics, Inc., developer and marketer of the VerifyNow System, today announced that the GRAVITAS (Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety) Trial found that in patients with high residual platelet reactivity, doubling the maintenance dose of clopidogrel did not reduce the risk of further ischemic events after percutaneous coronary intervention (PCI).” View full resource at news-medical.net
Most Recently Shared on November 19, 2010 at 8:26 pm By:
Stroke News: GRAVITAS Trial finds high dose of clopidogrel does not reduce risk of ischemic events: Accumetric... http://twurl.nl/hydpwz
Internal Medicine Article -
mdlinx.com — “Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial” View full resource at mdlinx.com
Most Recently Shared on November 1, 2010 at 11:50 am By:
Sandeep Pulim MD Physician, Doctor, and Health Communicator
Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergo... http://bit.ly/9SEOv2 #medicine
Phase II Study Showed Switching ACS-PCI Patients To Effient®/aspirin From Plavix®/aspirin Regimen Reduced Maximum Platelet Aggregation
medicalnewstoday.com — “A study evaluating the level of platelet aggregation achieved after switching from Plavix® (clopidogrel) 75 mg once-daily maintenance dosing plus aspirin to Effient® (prasugrel) 10 mg onc” View full resource at medicalnewstoday.com
Most Recently Shared on September 14, 2010 at 1:38 pm By:
MNT Clinical Trials Health News
Phase II Study Showed Switching ACS-PCI Patients To Effient®/aspirin From Plavix®/aspirin Regimen Reduced Maxi... http://mnt.to/3JHJ
Switching ACS patients to Effient therapy reduces Maximum Platelet Aggregation
news-medical.net — “A study evaluating the level of platelet aggregation achieved after switching from Plavix (clopidogrel) 75 mg once-daily maintenance dosing plus aspirin to Effient(prasugrel) 10 mg once-daily maintenance dosing (MD) in patients with acute coronary syndrome (ACS) was published today in the Journal of the American College of Cardiology.” View full resource at news-medical.net
Most Recently Shared on September 14, 2010 at 7:28 am By:
Stroke News: Switching ACS patients to Effient therapy reduces Maximum Platelet Aggregation: A study evaluating ... http://twurl.nl/jqo0zn
Double-Dose Clopidogrel Reduces Risk Of Death, Heart Attack Or Stroke In Patients Undergoing Angioplasty
medicalnewstoday.com — “A double-dose of the anti-clotting treatment clopidogrel, also known as Plavix, significantly reduces complications in heart patients undergoing angioplasty to clear blocked arteries.Sham” View full resource at medicalnewstoday.com
Most Recently Shared on September 3, 2010 at 3:00 pm By:
Double-Dose Clopidogrel Reduces Risk Of Death, Heart Attack Or Stroke In Patients Undergoing Angioplasty http://mnt.to/3JfD #stroke
Clopidogrel Dosing and CYP2C19: eMedicine Genomic Medicine
emedicine.medscape.com — “Overview: Clopidogrel (Plavix), a second-generation thienopyridine that inhibits platelet aggregation, is a mainstay, along with aspirin, in the management of patients with coronary artery disease, with acute coronary syndromes (ACS), and/or after percutaneous coronary interventions (PCI). Yet, a ...” View full resource at emedicine.medscape.com
Most Recently Shared on June 2, 2010 at 7:44 pm By:
Clopidogrel carries an increased risk of cardiovascular death in those with a certain chromosomal abnormalities. http://bit.ly/av2Ace
Advertisement
